Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: As we launch new branding in the coming months, you will see updates to the logos. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Glitazones

Glitazones

  • Diabetes (380)
    • Blood Glucose Meters (3)
    • Complications (133)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (66)
    • Drug-Induced Hypo/Hyperglycemia (112)
    • Monitoring (77)
    • Natural Medicines/Supplements (4)
    • Prevention (26)
    • Treatment (228)
      • Alpha-Glucosidase Inhibitors (19)
      • Amylin Agonist (12)
      • Bromocriptine (7)
      • Combination Products (10)
      • Gliptins (59)
      • Glitazones (85)
      • GLP-1 (33)
      • Incretin Enhancers/Mimetics (50)
      • Insulin (122)
      • Meglitinides (32)
      • Metformin (99)
      • SGLT2 Inhibitors (71)
      • Sulfonylureas (81)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (10)
  • Hyperglycemia (35)
  • Hypoglycemia (20)
  • Other (16)
  • Prediabetes (1)
  • Resources (172)
  • Thyroid Disorders (24)
61 - 75 of 85 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Patient Education: Tips for Sticking With Your Meds November 2013
PL Voices: Prevention and Treatment of Hypoglycemia June 2013
Guideline: Hypoglycemia and Diabetes: a Report of a Workgroup of the American Diabetes Association and the Endocrine Society (2013) June 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
PL Voices: Managing Diabetes During Sick Days March 2013
Commentary: Sick Day Management of Diabetes March 2013
Patient Education: How to Manage Sick Days with Diabetes March 2013
PL Voices: Managing Type 2 Diabetes in Elderly Patients November 2012
PL Voices: Concerns About Pioglitazone (Actos) and Bladder Cancer October 2012
Commentary: Glitazones and the Risk of Bladder Cancer October 2012
PL Voices: Management of Type 2 Diabetes in Kids and Teens July 2012
Guideline: Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada July 2012
Commentary: Actos (Pioglitazone) and Increased Risk of Bladder Cancer July 2011
Commentary: Metformin vs Pioglitazone for Polycystic Ovary Syndrome May 2011
Commentary: Restricted Use of Rosiglitazone-Containing Products October 2010
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved